Vimarsana
Biggest News Aggregation in the World

Page 38 - Lockup News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lockup. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lockup Today - Breaking & Trending Today

IPO Lockup Expiration Alert: Inozyme Pharma (INZY) - Vimarsana News

IPO Lockup Expiration Alert: Inozyme Pharma (INZY)

IPO Lockup Expiration Alert: Inozyme Pharma (INZY) BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - The lockup period of Boston, Massachusetts-based Inozyme Pharma (INZY) ends today, i.e., January 20, 2021. Inozyme Pharma is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of calcification disorders of the circulatory system, bones, and kidneys. The company's lead product candidate, INZ-701, is an enzyme replacement therapy for patients with a variety of calcification disorders linked primarily to Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 or ENPP1 Deficien...

IPO Lockup Expiration Alert: Nurix Therapeutics (NRIX) - Vimarsana News

IPO Lockup Expiration Alert: Nurix Therapeutics (NRIX)

IPO Lockup Expiration Alert: Nurix Therapeutics (NRIX) BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - The lockup period of San Francisco, California-based Nurix Therapeutics (NRIX) expires tomorrow , i.e., January 20, 2021. Nurix Therapeutics is a biopharmaceutical company developing oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's lead product candidate NX-2127 for the treatment of relapsed or refractory B-cell malignancies, is under pre-clinical testing. Filing of IND for NX-2127 is expected in the...

IPO Lockup Expiration Alert: Annexon (ANNX) - Vimarsana News

IPO Lockup Expiration Alert: Annexon (ANNX)

IPO Lockup Expiration Alert: Annexon (ANNX) BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - The lockup period of South San Francisco, California-based Annexon (ANNX) expires tomorrow, i.e., on January 20. Founded in 2011, Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for autoimmune and neurodegenerative diseases. There are three product candidates in the pipeline - ANX005 for intravenous (IV) administration in autoimmune and neurodegenerative disorders, ANX007 for intravitreal (IVT) administration for the treatment of neurodegenerative ophthalmic disorder...

Police to probe allegation of rape in Miri lockup - Vimarsana News

Police to probe allegation of rape in Miri lockup

KUCHING: Police are investigating the alleged rape of a 16-year-old girl by a male detainee while being held at the Miri police station lockup on Jan 9. Sarawak police commissioner Comm Datuk Aidi Ismail said the investigation by the state police headquarters and Miri district police was expected to be completed this week. He said police were looking into possible lapses and non-compliance with regulations that led to the occurrence of the alleged incident. "I have instructed my deputy Datuk Fisol Salleh to coordinate the investigation. Insyaallah, by this week we will wrap it up," he told re...

Why did cops put a teen in lock-up? Watchdog asks after girl raped by detainee in Miri | Malaysia - Vimarsana News

Why did cops put a teen in lock-up? Watchdog asks after girl raped by detainee in Miri | Malaysia

KUALA LUMPUR, Jan 17 — A watchdog group has said today that it was unnecessary for the police to hold a minor in a lock-up for a prolonged period of time, which had then led to her alleged rape by another detainee. In a statement, Eliminating Deaths and Abuse In Custody Together (EDICT) said that...